Back |
home / stock / canf / canf message board
Subject | By | Source | When |
---|---|---|---|
Unfortunately so, but was clear from prior financial | Spideyboy | investorshub | 08/29/2022 1:23:30 PM |
If company fails I will consider it my | midastouch017 | investorshub | 08/25/2022 12:00:34 PM |
Hi Spideyboy, | midastouch017 | investorshub | 08/25/2022 11:57:24 AM |
Can-Fite Reports Second Quarter 2022 Financial Results & | midastouch017 | investorshub | 08/25/2022 11:50:01 AM |
I, as well, have invested in this up | Ortiz | investorshub | 08/23/2022 12:53:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Can-Fite Biopharma Ltd Sponsored ADR Company Name:
CANF Stock Symbol:
NYSE Market:
Can-Fite Biopharma Ltd Sponsored ADR Website:
RAMAT GAN, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, invites investors to a webinar on August 8...
PETACH TIKVA, Israel, July 11, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced that it has submitted ...
Liver cirrhosis treatment global market is estimated to reach $29.2 billion by 2030 Ramat Gan, Israel, July 01, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that addr...